» Articles » PMID: 11897281

Frequency, Severity, and Duration of Rhinovirus Infections in Asthmatic and Non-asthmatic Individuals: a Longitudinal Cohort Study

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2002 Mar 19
PMID 11897281
Citations 222
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Rhinovirus infections cause exacerbations of asthma. We postulated that people with asthma are more susceptible to rhinovirus infection than people without the disease and compared the susceptibility of these groups.

Methods: We recruited 76 cohabiting couples. One person in every couple had atopic asthma and one was healthy. Participants completed daily diary cards of upper-respiratory-tract (URT) and lower-respiratory-tract (LRT) symptoms and measured peak expiratory flow twice daily. Every 2 weeks nasal aspirates were taken and examined for rhinovirus. Mixed models were used to compare risks of infection between groups. We also compared the severity and duration of infections.

Findings: We analysed 753 samples. Rhinovirus was detected in 10.1% (38/378) of samples from participants with asthma and 8.5% (32/375) of samples from healthy participants. After adjustment for confounding factors, asthma did not significantly increase risk of infection (odds ratio 1.15, 95% CI 0.71-1.87). Groups did not differ in frequency, severity, or duration of URT infections or symptoms associated with rhinovirus infection. First rhinovirus infection was associated more frequently with LRT infection in participants with asthma than in healthy individuals (12 of 28 infections vs four of 23, respectively, p=0.051). Symptoms of LRT associated with rhinovirus infection were significantly more severe (p=0.001) and longer-lasting in participants with asthma than in healthy participants (p=0.005).

Interpretation: People with atopic asthma are not at greater risk of rhinovirus infection than healthy individuals but suffer from more frequent LRT infections and have more severe and longer-lasting LRT symptoms.

Citing Articles

Harnessing Epigenetics: Innovative Approaches in Diagnosing and Combating Viral Acute Respiratory Infections.

Saha A, Ganguly A, Kumar A, Srivastava N, Pathak R Pathogens. 2025; 14(2).

PMID: 40005506 PMC: 11858160. DOI: 10.3390/pathogens14020129.


The Association Between Respiratory Viruses and Asthma Exacerbation in Children Visiting Pediatric Emergency Department: A Retrospective Cohort Study.

Lee W, Song J, Shin J, Choi S, Han M, Lee K J Clin Med. 2025; 14(4).

PMID: 40004841 PMC: 11856561. DOI: 10.3390/jcm14041311.


STING-dependent induction of neutrophilic asthma exacerbation in response to house dust mite.

Messaoud-Nacer Y, Culerier E, Rose S, Maillet I, Boussad R, Veront C Allergy. 2024; 80(3):715-737.

PMID: 39466641 PMC: 11891437. DOI: 10.1111/all.16369.


Treatment of Severe Asthma: Case Report of Fast Action of Mepolizumab in a Patient with Recent SARS-CoV-2 Infection.

Indolfi C, Dinardo G, Klain A, Decimo F, Miraglia Del Giudice M Life (Basel). 2024; 14(9).

PMID: 39337848 PMC: 11433087. DOI: 10.3390/life14091063.


Human Stimulator of Interferon Genes Promotes Rhinovirus C Replication in Mouse Cells In Vitro and In Vivo.

Goldstein M, Ignacio M, Loube J, Whorton M, Scull M Viruses. 2024; 16(8).

PMID: 39205256 PMC: 11358906. DOI: 10.3390/v16081282.